Through our global network of testing experts and analytical equipment including chromatography (HPLC, GC, GC/MS) and atomic absorption spectroscopy (AAS, GFA, FIAS), Our goal is to provide test services as efficiently as possible to maximize our customers' profits. For more information about our services, contact one of our experts today.
Note: this service is for Research Use Only and Not intended for clinical use.
Genotoxic impurities are compounds that directly or indirectly damage cellular DNA, produce genetic mutations or mutagenesis in vivo, and have carcinogenic potential or propensity. It is characterized by damage to human genetic material at very low concentrations, leading to genetic mutations and possibly tumorigenesis. Genotoxic impurities commonly found in the pharmaceutical industry include:
Sulfonates
Alkyl Halides and Esters
Hydrazines
Epoxides
Aromatic Compounds
β-lactam Related Impurities
Fig. 1. Structures of common sulfonate salts1
Because genotoxic impurities are highly toxic and threaten the public's medication safety, they need to be risk assessed and controlled. Alfa Chemistry is an expert in the analytical chemistry industry, providing solutions for the development and analysis of chemical methods for the detection of trace amounts of genetic impurities for the complex pharmaceutical industry. We design custom-compliant inspection methods according to your needs and provide you with an evaluation report. If you have any questions about genotoxic impurities analysis, please feel free to contact us.
Inductively-Coupled Plasma Mass Spectrometry (ICP-MS)
Inductively Coupled Plasma Optical Emission Spectrometer (ICP-OES)
Gas Chromatography (GC)
Gas Chromatography-Mass Spectrometry (GC-MS)
Fourier Transform Infrared Spectroscopy (FT-IR)
Liquid Chromatography-Ultraviolet Spectrometry (LC-UV)
Liquid Chromatography-Mass Spectrometry (LC-MS)
Capillary Electrophoresis (CE)
Supercritical Fluid Chromatography (SFC)
Nuclear Magnetic Resonance Spectroscopy (NMR)
ICH M7 (R1) - Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk
ICH S2 (R1) - Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
ICH Q8 (R2) - Guidance for Industry: Pharmaceutical Development
Short Detection Cycle
Competitive Price
Experienced Team of Experts
First-class Equipment
Reliable Results
Familiarity with Various Standards
Jouyban, Abolghasem & Parsa Khankandi, Hamed. (2012). Genotoxic Impurities in Pharmaceuticals. 'Toxicity and Drug Testing' 387-414.
Do not know how to place an order, please refer to the flow chart shown below.
Submit quotation request |
A technical manager will contact you within 24 hours |
You will review and approve the final price and place an order |
Confirm with you and make the payment |
Instruct you to ship your samples and form |
Analytic report delivery |